A new tool for clinicians, Induced menopause in women with endometriosis, is now available on the BMS website.
The BMS has produced a document in response to the ongoing HRT shortages and to provide guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies.
Are you passionate about women’s health advocacy? Could you lead the broad range of lay voices that support the Royal College of Obstetricians and Gynaecologists’ work to improve women’s health?
Further to our letter sent on 9 September to Dr June Raine, Interim CEO of the MHRA and to the questions we asked under the Freedom of Information Act, responses have now been received (PDF, 172KB). The medical advisory council of the BMS has reviewed these responses and the following letter was sent to Dr [...]
Today, Friday 18 October, is World Menopause Day, established in 2009 by the International Menopause Society.
To coincide with World Menopause Day, 18 October, the British Menopause Society has launched a series of seven short videos covering different aspects of the menopause.
Review of the data published in the Lancet last Friday, 11 October 2019.
The British Menopause Society welcomes the Government’s new measures that restrict exporting hormone replacement therapy (HRT) outside the UK.
The British Menopause Society has produced this further update on the current availability of HRT products in response to the ongoing HRT shortages. The objective of this is to provide guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies.
The medical advisory council of the BMS has reviewed the recommendations issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) on 30 August. The following letter was sent to Dr June Raine, interim CEO of the MHRA.